Question
My assignment is to perform a financial assessment using Yahoo Finance statements. I chose Johnson and Johnson (JNJ). However, where do I find the shares
My assignment is to perform a financial assessment using Yahoo Finance statements. I chose Johnson and Johnson (JNJ). However, where do I find the shares outstanding on the financial statement? I can't figure it out. See below- I guessed on my JNJ below. The instructor also gave us an example of the company Abbott (ABT) to view below. I used the example to figure out most of the assessment. However, I don't understand why he put "Other" figures under Income statement for depreciation instead of depreciation on cash flow. Can someone explain? Thank you!
Johnson and Johnson (JNJ) | |||||
In Thousands (except for per share items) | 2017 | 2016 | 2015 | ||
Price per share | 142.360001 | 112.979988 | $ 96.856758 | ||
Revenues | 71,890,000 | 70,074,000 | 74,331,000 | ||
Depreciation | 3,754,000 | 3,746,000 | 3,895,000 | ||
EBIT | 20,529,000 | 19,748,000 | 21,096,000 | ||
Income Before Tax | 19,803,000 | 19,196,000 | 20,563,000 | ||
Income Tax | 3,263,000 | 3,787,000 | 4,240,000 | ||
Income After Tax | 16,540,000 | 15,409,000 | 16,323,000 | ||
Dividends | 8,621,000 | 8,173,000 | 7,768,000 | ||
Operating CF | 21,020,000 | 19,707,000 | 20,751,000 | ||
Current Assets | 65,032,000 | 60,210,000 | 55,744,000 | ||
Total Assets | 141,208,000 | 133,411,000 | 130,358,000 | ||
Current Liabilities | 26,287,000 | 27,747,000 | 25,031,000 | ||
Lont-term Debt | 44,503,000 | 34,514,000 | 35,575,000 | ||
Total Liabilities | 70,790,000 | 62,261,000 | 60,606,000 | ||
Net Working Capital | 38,745,000 | 32,463,000 | 30,713,000 | ||
Change in NWC | 6,282,000 | 1,750,000 | 30,703,260 | ||
Capital Expenditure | 3,226,000 | 3,463,000 | 3,714,000 | ||
Free Cash Flow | 17,964,000 | 21,420,000 | -6,238,260 | ||
FCF per share | 6,441.25 | -2,178.24 | |||
Total Equity | 70,418,000 | 71,150,000 | 69,752,000 | ||
Shares Outstanding | 2,789 | 2,813 | 2,863.90 | ||
Book value per share | 25,249.38 | 25,294.18 | 24,355.60 | ||
Earnings per share | 5,930.65 | 5,477.98 | 5,699.57 | ||
Dividend per share | -3091.18 | -2905.54 | -2712.39 | ||
2016 | 2015 | 2014 | Benchmark | ||
Current Ratio | 2.47 | 2.17 | 2.23 | 1.8 | |
Debt Ratio | 50.13% | 46.67% | 46.49% | 0.57 | |
TAT Ratio | 0.51 | 0.53 | 0.57 | 0.9 | |
ROE | 23.49% | 21.66% | 23.40% | 12% | |
Profit Margin Ratio | 23.01% | 21.99% | 21.96% | 16% |
EXAMPLE GIVEN BY INSTRUCTOR
Financial Performance Assessment | ||||||
Abbott Laboratories (ABT) | ||||||
In Millions (except for per share items) | 2016 | 2015 | 2014 | 2013 | ||
Price per share | 38.41 | 44.91 | 45.02 | 38.33 | End of year-historical data EOY | |
Revenues | 20,853 | 20,405 | 20,247 | 19,657 | revenues-Income statement | |
Depreciation | 550 | 601 | 555 | 588 | Others income statement | |
EBIT | 3,185 | 2,867 | 2,581 | 2,133 | EBIT-TOI/EN- Income statement | |
Income Before Tax | 1,413 | 3,183 | 2,518 | 2,041 | Income Before Tax | |
Income Tax | 350 | 577 | 797 | 53 | Income Tax Expense | |
Income After Tax | 1,063 | 2,606 | 1,721 | 1,988 | Net Income From Continuing Ops | |
Dividends | -1,539 | -1,443 | -1,342 | -882 | Dividends Paid-CASH FLOW | |
Operating CF | 3,385 | 2,891 | 2,339 | 2,668 | ||
Current Assets | 26,776 | 14,155 | 13,556 | 19,247 | ||
Total Assets | 52,666 | 41,247 | 41,207 | 42,953 | ||
Current Liabilities | 6,660 | 9,186 | 10,467 | 9,507 | ||
Lont-term Debt | 25,468 | 10,850 | 9,214 | 8,275 | ||
Total Liabilities | 32,128 | 20,036 | 19,681 | 17,782 | ||
Net Working Capital | 20,116 | 4,969 | 3,089 | 9,740 | ||
Change in NWC | 15,147 | 1,880 | -6,651 | |||
Capital Expenditure | -1,121 | -1,110 | -1,077 | -1,145 | ||
Free Cash Flow | -12,883 | -99 | 7,913 | 1,523 | ||
FCF per share | -8.75 | 5.22 | ||||
Total Equity | 20,538 | 21,211 | 21,526 | 25,171 | ||
Shares Outstanding | 1,473 | 1,473 | 1,515 | 1,548 | ||
Book value per share | 13.94 | 14.40 | 14.21 | 16.26 | ||
Earnings per share | 0.72 | 1.77 | 1.14 | 1.28 | ||
Dividend per share | 1.04 | 0.98 | 0.89 | 0.57 | ||
2016 | 2015 | 2014 | 2013 | Benchmark | ||
Current Ratio | 4.02 | 1.54 | 1.30 | 2.02 | 1.8 | |
Debt Ratio | 61.00% | 48.58% | 47.76% | 41.40% | 0.57 | |
TAT Ratio | 0.40 | 0.49 | 0.49 | 0.46 | 0.9 | |
ROE | 5.18% | 12.29% | 7.99% | 7.90% | 12% | |
Profit Margin Ratio | 5.10% | 12.77% | 8.50% | 10.11% | 16% |
Step by Step Solution
There are 3 Steps involved in it
Step: 1
Get Instant Access to Expert-Tailored Solutions
See step-by-step solutions with expert insights and AI powered tools for academic success
Step: 2
Step: 3
Ace Your Homework with AI
Get the answers you need in no time with our AI-driven, step-by-step assistance
Get Started